The FDA has approved Restylane Lyft with lidocaine for augmentation of the chin region for adults aged 21 years and older ...

Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that it presented new data from its Injectable Aesthetics portfolio and pipeline at the American Society for ...

FORT WORTH, Texas, June 29, 2021 /PRNewswire/ -- Galderma announced today the U.S. Food and Drug Administration (FDA) has approved Restylane ® Contour for cheek augmentation and correction of midface ...

ZUG, Switzerland--(BUSINESS WIRE)-- Galderma (SWX:GALD) announces positive first results from a trial designed to explore the benefits of Restylane ® Lyft™ or Contour™ in combination with Sculptra ® ...

Following interim analysis at three months presented earlier this year, a six-month extension study was conducted to capture the durability of treatment effects after nine months 1 Galderma continues ...

Please provide your email address to receive an email when new articles are posted on . Restylane Contour has been approved by the FDA for cheek augmentation and the correction of midface contour ...

MILFORD, Pa., Jan. 10, 2022 /PRNewswire-PRWeb/ -- Defined and plump facial cheeks are a sign of youth, but as Zoom calls have shown many in their 40s and beyond, the once youthful contour of the ...

(MENAFN- PR Newswire) FORT WORTH, Texas, Sept. 30, 2021 /PRNewswire/ -- Galderma, the world's largest independent dermatology company, today marks the 25th anniversary of RESTYLANE®. Since launching ...

Restylane Eyelight is the first and only product in the U.S. to use NASHA ® Technology to improve the appearance of undereye hollows for up to 18 months 1 DALLAS, June 5, 2023 /PRNewswire/ -- Galderma ...

Galderma has revealed positive final data from a phase IV first-of-its-kind trial exploring the benefits of Restylane Lyft or Contour in combination with Sculptra to address the aesthetic concerns of ...